The cyclosporine transdermal transfer possibility study on model systems
https://doi.org/10.15825/1995-1191-2019-1-135-141
Abstract
Aim: to develop the emulsion transdermal therapeutic system (TTS) of cyclosporine and the research of its diffusion from TTS.
Materials and methods. The quantitative evaluation of cyclosporine in model media was performed on liquid chromatograph Agilent 1100 G1311 with spectrophotometric detector G1315B (Germany). For the production of the emulsion matrix, the Heidolph DIAX900 disperser (Germany) and the ultrasonic homogenizer Hielscher UIS250V (Germany) were used. The cyclosporine diffusion from TTS through Strat-M membrane (25 mm in diameter, Merck Millipore) was studied using Copley diffusion analyser (Great Britain).
Results. Using the developed method of micro-HPLC, it was established that the amount of cyclosporine passed through the Strat-M membrane over 24 hours from 10 sm2 TTS, containing 173 mg of the substance, was 5.9 mg. The estimated blood concentration is ~ 50 ng/ml which corresponds to the therapeutic maintenance blood concentration during organ transplantation (50–75 ng/ml).
Conclusion. The model studies demonstrate the possibility of the cyclosporine transdermal transfer.
About the Authors
E. G. Kuznetsova
V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
1, Shchukinskaya str., Moscow, 123182.
Tel. (499) 193-86-62.
O. M. Kuryleva
V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
L. A. Salomatina
V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
V. Yu. Belov
V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
V. I. Sevastianov
V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Okovityj SV. Klinicheskaya farmakologiya immunodepressantov. Obzory po klinicheskoj farmakologii i lekarstvennoj terapii. 2003; 2 (2): 2–34.
2. Kudryavceva AV, Balabolkina II. Ciklosporin v terapii tyazhelyh form atopicheskogo dermatita u detej. Voprosy klinicheskoj pediatrii. 2009; 4 (5): 18–21.
3. Luchihina EL. Ciklosporin A pri revmatoidnom artrite: sovremennye dannye. Sovremennaya revmatologiya. 2009; 3 (3): 39–44.
4. Gosudarstvennaya farmakopeya XIII OFS.1.1.0013.15. Statisticheskaya obrabotka rezul’tatov khimicheskogo eksperimenta.
5. Shepel’ VS. O sostavlenii smesey rastitel’nykh masel dlya kosmeticheskikh kompozitsiy. Available from: http://www.tusheflora.ru/review/publications/2010/o_sostavlenii_smesej_rastitelnih_masel_dlya_kosmeticheskih_kompozitcij/.
6. Sang GL, Jong BK, Sung RK, Chae JK, Dong WY, Ho YY, Seong SK, Young WC. Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with Transcutol P. Drug Development and Industrial Pharmacy. 2016; 42 (10): 1636–1642.
7. Arzamascev AP, Bagirova VL, Nechaeva EB, Ledovskih MV, Sadchikova NP, Milkina SE, Bajkova VN. Izuchenie vysvobozhdeniya ciklosporina A in vitroiz kapsulirovannyh lekarstvennyh form. Himiko-farmacevticheskij zhurnal. 2006; 2: 40–43.
8. Ryzhikova VA, Tikhobayeva AA, Salomatina LA, Kursakov SV, Kuznetsova EG, Kuryleva OM, Sevastianov VI. Effect of the transfer activator on functional properties of the bromocain matrix transdermal therapeutic systems. Inorganic Materials: applied research.2014; 5 (5): 498– 503. Ryzhikova VA, Tikhobayeva AA, Salomatina LA, Kursakov SV, Kuznetsova EG, Kuryleva OM, Sevastianov VI, 2014, published in Perspektivnye Materialy, 2014, 2: 26–32.
9. Janani NS, Kumar GB, Balakrishna P, Sruthi D, Kumar MS, Mantry S. A review of Strat-M membrane. International journal of innovative pharmaceutical sciences and research, 2014, 2 (4): 962–977.
10. Strat-M membrane and sunscreen. Substituting Strat-M membrane for human skin in evaluating effect of encapsulation on diffusion of sunscreen formulations. Available from: http://www.merckmillipore.com/.
11. Joshi V, Brewster D, Colonero P. In vitrodiffusion studies in transdermal research: a synthetic membrane model in place of human skin. Drug development and delivery. 2012; 12 (12): 40–42.
12. Karadzovska D, Riviere JE. Assessing vehicle effects on skin absorption using artificial membrane assays. Europian Journal of Pharmaceutical Sciences. 2013; 50 (5): 569–576.
Review
For citations:
Kuznetsova E.G., Kuryleva O.M., Salomatina L.A., Belov V.Yu., Sevastianov V.I. The cyclosporine transdermal transfer possibility study on model systems. Russian Journal of Transplantology and Artificial Organs. 2019;21(1):135-141. (In Russ.) https://doi.org/10.15825/1995-1191-2019-1-135-141
Views:
897
Email this article 